Skip to main content
OpenTrials
Completed

NCT Number: NCT01690039

Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis

Purpose

1. To compare the performance of the two currently employed urinary acidifications tests in stone formers, the furosemide/fludrocortisone and ammonium chloride loading test. 2. To study the impact of polymorphisms in the genes ATP6V1B1, ATP6V0A4 and SLC4A1 on urinary acidification in stone formers.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • One or more episodes of nephrolithiasis

Exclusion criteria

  • Absence of informed consent
  • All conditions affecting renal acidification
  • Pregnancy
  • Nursing

Treatment and study plan

Furosemide-Fludrocortisone-Test (test for urinary acidification)

Drug

The presence of a lack of urinary acidification will be assessed by an appropriate test in all patients.

Other names: Application of Furosemide (Lasix® ) and Fludrocortisone (Florinef®)

Primary outcomes

  1. Capability of urinary acidification

    Time frame: Five to six hours

Secondary outcomes

  1. Polymorphisms in the ATP6V1 gene

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Registry information

Official study title

Comparison of Furosemide/Fludrocortisone With Ammonium Chloride Loading Test in the Diagnosis of Incomplete dRTA in Kidney Stone Formers

Important dates

Study start
2012
Primary completion
2016
Study completion
2017
First posted
Sep 21, 2012
Registry last updated
Oct 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.